SCHEMBL19080127

SCHEMBL19080127

c1ccc(-c2ccc(-c3c4ccccc4c(-c4cccc(-c5cc6ccccc6c6c5oc5ccc7ccccc7c56)c4)c4ccccc34)c3ccccc23)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.41
AHR P35869 3/20 0.41
CYP1A1 P04798 2/20 0.41
CYP1A2 P05177 2/20 0.41
PAX8 Q06710 2/20 0.41
FYN P06241 1/20 0.41
MAPK3 P27361 1/20 0.41
KDM4E B2RXH2 5/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
GPR84 Q9NQS5 4/20 0.36
RECQL P46063 1/20 0.34
ALDH1A1 P00352 3/20 0.34
RAB9A P51151 2/20 0.34
ADORA1 P30542 2/20 0.34
MAOB P27338 1/20 0.34
ADORA3 P0DMS8 1/20 0.34
ADORA2A P29274 1/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079966 0.94 ABCG2 (0.42) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL19079944 0.92 ABCG2 (0.45) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL18718002 0.91 ABCG2 (0.46) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL19080108 0.90 ABCG2 (0.43) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL19079999 0.89 GPR84 (0.44) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL18471555 0.88 ABCG2 (0.50) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL19080125 0.87 MEN1 (0.35) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL19080128 0.87 CYP1A1 (0.40) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL26491846 0.86 ABCG2 (0.42) ABCG2AHRCYP1A1CYP1A2PAX8
SCHEMBL18717995 0.86 ABCG2 (0.48) ABCG2AHRCYP1A1CYP1A2PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ABCG2 4758/4885AHR 2211/4885CYP1A1 147/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ABCG2 4758/4885AHR 2211/4885CYP1A1 147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.